Clinical Trials Directory

Trials / Conditions / Indolent Non-Hodgkin's Lymphoma

Indolent Non-Hodgkin's Lymphoma

7 registered clinical trials studyying Indolent Non-Hodgkin's Lymphoma.

StatusTrialSponsorPhase
WithdrawnA Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab a
NCT02576275
SecuraBioPhase 3
TerminatedPhase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's L
NCT01889797
PrECOG, LLC.Phase 2
TerminatedEntospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies
NCT01796470
Gilead SciencesPhase 2
CompletedBendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Tr
NCT01500083
Lundbeck Canada Inc.Phase 3
CompletedSafety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymph
NCT01306643
Gilead SciencesPhase 1 / Phase 2
CompletedStudy to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-
NCT01088048
Gilead SciencesPhase 1
CompletedProspective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent L
NCT00582270
Memorial Sloan Kettering Cancer Center—